Kodiak Sciences Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Kodiak Sciences Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($61.46M) | Nov 13, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($54.31M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($54.31M) | Aug 13, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($57.46M) | Aug 13, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($57.46M) | Nov 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($57.46M) | May 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($43.95M) | Nov 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($45.12M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($45.12M) | Aug 13, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($43.04M) | Nov 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($43.04M) | May 14, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($43.04M) | Aug 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($50.01M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($80.19M) | Aug 14, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($80.19M) | Nov 14, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($70.78M) | Nov 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($70.78M) | May 15, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($70.78M) | Aug 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($77.04M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($90.63M) | Aug 14, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($62.35M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($55.51M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($59.07M) | May 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($46.63M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($47.98M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($46.06M) | May 14, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($54.50M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($84.83M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($74.62M) | May 15, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($79.48M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($92.07M) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($95.77M) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($67.54M) | Nov 9, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($55.91M) | Aug 9, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($50.56M) | May 10, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($36.66M) | Nov 9, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($26.78M) | Aug 9, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($25.72M) | May 10, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($12.73M) | Nov 9, 2020 |
| Q2 | 2020 | Jun 30, 2019 | ($11.81M) | Aug 10, 2020 |